ALK and non-small cell lung carcinoma: A Patient With Novel &lt;i&gt;PPP1CB&lt;/i&gt; &lt;i&gt;-ALK&lt;/i&gt; Fusion Advanced NSCLC Achieved Long Survival From Alectinib: A Case Report.